Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00227695
Status:
COMPLETED
Last Update Posted:
2019-05-15
First Post:
2005-09-26
Brief Title:
Rituximab in Treating Patients With Follicular Non-Hodgkins Lymphoma
Sponsor:
Swiss Group for Clinical Cancer Research
Organization:
Swiss Group for Clinical Cancer Research
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| recurrent grade 3 follicular lymphoma | View |
| stage I grade 1 follicular lymphoma | View |
| stage I grade 2 follicular lymphoma | View |
| stage I grade 3 follicular lymphoma | View |
| stage III grade 1 follicular lymphoma | View |
| stage III grade 2 follicular lymphoma | View |
| stage III grade 3 follicular lymphoma | View |
| stage IV grade 1 follicular lymphoma | View |
| stage IV grade 2 follicular lymphoma | View |
| stage IV grade 3 follicular lymphoma | View |
| contiguous stage II grade 1 follicular lymphoma | View |
| contiguous stage II grade 2 follicular lymphoma | View |
| contiguous stage II grade 3 follicular lymphoma | View |
| noncontiguous stage II grade 1 follicular lymphoma | View |
| noncontiguous stage II grade 2 follicular lymphoma | View |
| noncontiguous stage II grade 3 follicular lymphoma | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |